AOS vs LAB · P/E 19, rev $3.83B vs rev $174.4M
Smith AO Corporation (AOS) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Smith AO Corporation (AOS) is a specialty industrial machinery company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported AOS revenue for 2025-12-31 was $3.83B. Net income was $546.2M. Revenue was up 0.3% from 2024-12-31 to 2025-12-31. AOS currently screens at market cap $9.73B and trailing P/E 19.1.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
AOS currently screens at market cap $9.73B and trailing P/E 19.1. LAB currently screens at market cap $317.1M.
Not investment advice. Open the AOS and LAB stock pages for the full models.
Not investment advice.